- Law & professional services
- Marketing and advertising
- Retail and leisure
- Transport and infrastructure
- Life & Style
Modal titleA world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Related news from City A.M.Shares in Astrazeneca reached a record high today after the company kicked off September with strong results from two drug [...]Astrazeneca today took a leap forward for lupus patients who have been waiting for decades for a breakthrough, bouncing back [...]Astrazeneca got a double immune boost today as one of its drugs was given orphan status in the US, while [...]Astrazeneca took a blow this morning as it revealed that trials of a lung cancer drug had not lived up [...]A new Astrazeneca drug might help patients with heart failure, half of whom die within five years of being diagnosed, [...]Shares in Astrazeneca rose more than five per cent this morning after bumper sales of new cancer drugs fuelled a [...]Drugmaker Glaxosmithkline is set to announce the former finance boss of Astrazeneca as its new chair to oversee the breakup [...]
Our healthcare system is trapped in an impasse as pharmaceutical firms struggle to fund medical innovationsThe price of technological innovations in health care has once again been brought into focus. Orkambi, a new pharmaceutical treatment [...]By Kyle Caldwell from interactive investor. Looking for equity-based ISA inspiration? We run through the investment checklist of the Berkshire [...]Strong growth in Chinese demand for new medicines helped Astrazeneca return to growth in 2018, it said today. The figures [...]
Content tagged with "AstraZeneca"